Your Health, We Care
Eli Lilly and Company in the United States developed and produced selpercatinib. The specification of selpercatinib is 40mg/120 capsules, and the price is approximately $662. There are various manufacturers of selpercatinib, and prices vary depending on the manufacturer, selpercatinib, and sales channels, and are influenced by multiple factors.
Selpercatinib is a targeted therapy for specific gene mutations (such as RET fus···【more】
Release date：2026-02-27Recommended：32
Selpercatinib is a targeted therapy designed for specific gene mutations (such a···【more】
Release date：2026-02-27Recommended：28
Serpatinib is an important drug, and its application in the medical field has at···【more】
Release date：2024-12-24Recommended：213
Serpatinib is an important therapeutic drug, and its price, side effects and sid···【more】
Release date：2024-12-23Recommended：222
With the rapid development of medical technology, new drugs are emerging, among ···【more】
Release date：2024-12-23Recommended：202
Serpatinib is an important drug, and its price and precautions in the process of···【more】
Release date：2024-12-23Recommended：225
As a RET gene-targeted drug, Selpercatinib can effectively treat RET-related can···【more】
Release date：2024-08-15Recommended：255
Serpatinib is an innovative cancer treatment that targets mutations in the RET g···【more】
Release date：2024-08-15Recommended：280
Selpercatinib has a significant effect on RET-mutated cancers, especially in the···【more】
Release date：2024-08-15Recommended：258
